Capital World Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.48B | Buy |
|
|||||
|
2025
Q1 | $4.52B | Buy |
|
|||||
|
2024
Q4 | $3.91B | Buy |
|
|||||
|
2024
Q3 | $4.54B | Buy |
|
|||||
|
2024
Q2 | $3.64B | Buy |
|
|||||
|
2024
Q1 | $1.91B | Sell |
|
|||||
|
2023
Q4 | $3.1B | Sell |
|
|||||
|
2023
Q3 | $2.93B | Buy |
|
|||||
|
2023
Q2 | $3.13B | Buy |
|
|||||
|
2023
Q1 | $3.3B | Buy |
|
|||||
|
2022
Q4 | $3.9B | Buy |
|
|||||
|
2022
Q3 | $2.79B | Buy |
|
|||||
|
2022
Q2 | $1.5B | Buy |
|
|||||
|
2022
Q1 | $980M | Buy |
|
|||||
|
2021
Q4 | $54.1M | Hold |
|
|||||
|
2021
Q3 | $60.2M | Hold |
|
|||||
|
2021
Q2 | $54.1M | Sell |
|
|||||
|
2021
Q1 | $49.8M | Hold |
|
|||||
|
2020
Q4 | $45.8M | Hold |
|
|||||
|
2020
Q3 | $51.3M | Hold |
|
|||||
|
2020
Q2 | $52.2M | Hold |
|
|||||
|
2020
Q1 | $38.4M | Buy |
|
|||||
|
2019
Q4 | $15.9M | Hold |
|
|||||
|
2019
Q3 | $11.1M | Hold |
|
|||||
|
2019
Q2 | $9.99M | Hold |
|
|||||
|
2019
Q1 | $12.9M | Hold |
|
|||||
|
2018
Q4 | $10M | Hold |
|
|||||
|
2018
Q3 | $12.1M | Hold |
|
|||||
|
2018
Q2 | $13.6M | Hold |
|
|||||
|
2018
Q1 | $16.4M | Hold |
|
|||||
|
2017
Q4 | $17.5M | Hold |
|
|||||
|
2017
Q3 | $16.2M | Hold |
|
|||||
|
2017
Q2 | $11M | Hold |
|
|||||
|
2017
Q1 | $7.06M | Hold |
|
|||||
|
2016
Q4 | $5.16M | Sell |
|
|||||
|
2016
Q3 | $38.9M | Hold |
|
|||||
|
2016
Q2 | $31.8M | Sell |
|
|||||
|
2016
Q1 | $122M | Hold |
|
|||||
|
2015
Q4 | $183M | Sell |
|
|||||
|
2015
Q3 | $156M | Sell |
|
|||||
|
2015
Q2 | $247M | Sell |
|
|||||
|
2015
Q1 | $223M | Buy |
|
|||||
|
2014
Q4 | $93.6M | Buy |
|
|||||
|
2014
Q3 | $66.3M | Hold |
|
|||||
|
2014
Q2 | $53.6M | Sell |
|
|||||
|
2014
Q1 | $58.1M | Sell |
|
|||||
|
2013
Q4 | $67.8M | Sell |
|
|||||
|
2013
Q3 | $77.6M | Sell |
|
|||||
|
2013
Q2 | $52.7M | Buy |
|